Publications by authors named "Johan Bratt"

Claim this Profile
M
Maintenance of improvement in spinal mobility, physical function and quality of life in patients with ankylosing spondylitis after 5 years in a clinical trial of adalimumab.
Désirée van der Heijde, Maxime Breban, Dale Halter, Gino DiVittorio, Johan Bratt

Rheumatology (Oxford)· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of infliximab versus conventional combination treatment in methotrexate-refractory early rheumatoid arthritis: 2-year results of the register-enriched randomised controlled SWEFOT trial.
Jonas K Eriksson, Johan A Karlsson, Johan Bratt, Ingemar F Petersson, Ronald F van Vollenhoven

Ann Rheum Dis· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in early rheumatoid arthritis: 2-year quality-of-life results of the randomised, controlled, SWEFOT trial.
Johan A Karlsson, Martin Neovius, Jan-Åke Nilsson, Ingemar F Petersson, Johan Bratt

Ann Rheum Dis· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biological vs. conventional combination treatment and work loss in early rheumatoid arthritis: a randomized trial.
Jonas K Eriksson, Martin Neovius, Johan Bratt, Ingemar F Petersson, Ronald F van Vollenhoven

JAMA Intern Med· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Macrophage migration inhibitory factor (MIF) and thyroid hormone alterations in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV).
Mårten Wendt, Ola Börjesson, Aune Avik, Johan Bratt, Björn Anderstam

Mol Med· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conventional combination treatment versus biological treatment in methotrexate-refractory early rheumatoid arthritis: 2 year follow-up of the randomised, non-blinded, parallel-group Swefot trial.
Ronald F van Vollenhoven, Pierre Geborek, Kristina Forslind, Kristina Albertsson, Sofia Ernestam, Johan Bratt

Lancet· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In early rheumatoid arthritis, patients with a good initial response to methotrexate have excellent 2-year clinical outcomes, but radiological progression is not fully prevented: data from the methotrexate responders population in the SWEFOT trial.
Hamed Rezaei, Saedis Saevarsdottir, Kristina Forslind, Kristina Albertsson, Helena Wallin, Johan Bratt

Ann Rheum Dis· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-mobility group box-1 protein (HMGB1) is increased in antineutrophilic cytoplasmatic antibody (ANCA)-associated vasculitis with renal manifestations.
Annette Bruchfeld, Mårten Wendt, Johan Bratt, Abdul R Qureshi, Sangeeta Chavan

Mol Med· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of response to methotrexate in early DMARD naive rheumatoid arthritis: results from the initial open-label phase of the SWEFOT trial.
Saedis Saevarsdottir, Helena Wallin, Maria Seddighzadeh, Sofia Ernestam, Pierre Geborek, Johan Bratt

Ann Rheum Dis· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temporomandibular joint bone tissue resorption in patients with early rheumatoid arthritis can be predicted by joint crepitus and plasma glutamate level.
Anna-Kari Hajati, Karin Näsström, Per Alstergren, Johan Bratt, Sigvard Kopp

Mediators Inflamm· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endogenous glutamate in association with inflammatory and hormonal factors modulates bone tissue resorption of the temporomandibular joint in patients with early rheumatoid arthritis.
Anna-Kari Hajati, Per Alstergren, Karin Näsström, Johan Bratt, Sigvard Kopp

J Oral Maxillofac Surg· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fcgamma receptor type IIIA genotype and response to tumor necrosis factor alpha-blocking agents in patients with rheumatoid arthritis.
Alf Kastbom, Johan Bratt, Sofia Ernestam, Jon Lampa, Leonid Padyukov

Arthritis Rheum· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduction of temporomandibular joint pain after treatment with a combination of methotrexate and infliximab is associated with changes in synovial fluid and plasma cytokines in rheumatoid arthritis.
Sigvard Kopp, Per Alstergren, Sofia Ernestam, Silvi Nordahl, Par Morin, Johan Bratt

Cells Tissues Organs· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Chronic granulomatous disease--not only the lack of oxygen radicals].
Jan Palmblad, Hans Gyllenhammar, Johan Bratt, Anders Ahlin

Lakartidningen· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Wegener's granulomatosis is associated with organ-specific antiendothelial cell antibodies.
Carolina Holmén, Marta Christensson, Erna Pettersson, Johan Bratt, Pär Stjärne

Kidney Int· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Etanercept versus etanercept plus methotrexate: a registry-based study suggesting that the combination is clinically more efficacious.
Ronald F van Vollenhoven, Sofia Ernestam, Anders Harju, Johan Bratt, Lars Klareskog

Arthritis Res Ther· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum sFAS levels are elevated in ANCA-positive vasculitis compared with other autoimmune diseases.
Marta Christensson, Erna Pettersson, Kjell Eneslätt, Birger Christensson, Johan Bratt

J Clin Immunol· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Re: Cluster headache is not associated with signs of a systemic inflammation.
Ingela Nilsson Remahl, Elisabet Waldenlind, Johan Bratt, Karl Ekbom

Headache· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis